Sign in
4

Changes in Ownership

REGENERON PHARMACEUTICALS, INC. Filed Acc 0001968202-24-000130

Director sold 100 shares at an average $1,048.78 ($104,878)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

RYAN ARTHUR F · Director

Table I: Non-derivative

17 lines
Date Transaction Shares Price Value Owned after D/I
2024-10-01 Sale : show line 1 in the form 10b5-1 −3 $1,041.35 $3,124 17,679 D
2024-10-01 Sale : show line 2 in the form 10b5-1 −1 $1,042.31 $1,042 17,678 D
2024-10-01 Sale : show line 3 in the form 10b5-1 −5 $1,043.39 $5,217 17,673 D
2024-10-01 Sale : show line 4 in the form 10b5-1 −9 $1,044.62 $9,402 17,664 D
2024-10-01 Sale : show line 5 in the form 10b5-1 −7 $1,045.27 $7,317 17,657 D
2024-10-01 Sale : show line 6 in the form 10b5-1 −9 $1,046.53 $9,419 17,648 D
2024-10-01 Sale : show line 7 in the form 10b5-1 −12 $1,047.44 $12,569 17,636 D
2024-10-01 Sale : show line 8 in the form 10b5-1 −12 $1,048.54 $12,582 17,624 D
Open-market sales · 100 sh · avg $1,048.78 · $104,878
Loading xslF345X05/edgardoc.xml…